tomasccc52
10 Dec 2019
Thoughts on Future Market Cap I would love to know how many open label participants have thrown the s##t in the trash by now. They likely signed up because they thought they had surely been on placebo since it didnt work. Now they no none of it does. Martin likely tried it and as a young man decided not to take part and tarnish his reputation. Other old dudes grabbing what they can before fading away.
TonyDeadeye
10 Dec 2019
Thoughts on Future Market Cap It’s a shame it’s come to this. Feel for those who’ve been caught out but mightily relieved I got out when I did. Alarm bells started to ring for me as far back as February 2018 when Derek Martin resigned at a relatively young age. Directors simply do not quit “apparent†multibaggers like FUM especially when they’re sitting on hundreds of thousands of “cheap†share options. That didn’t make sense. Then alarm bell number 2 came with the September 2018 “business updateâ€. After many months of “strong†negotiations where there was talk of a mega deal involving punchy numbers all of a sudden the management thought it was best to go it alone even if it meant causing a 70% dilution. Barder also withdrew from answering emails, All that didn’t make sense. Alarm bell number 3. Reading the accounts filed at Companies House showing the directors had paid themselves massive bonuses which coincidently seemed to cover their own share placing involvement, but IMO misleading shareholders into thinking they were really dipping into their own pockets (ie their own salaries and not an unwarranted huge bonus). Alarm bell 4 - the interims released last September. TPR knocked back 6 months and again misleading financial highlights regarding the cash position - mentioning the post period tax credit but not the £3.5 million trade payables. Very naughty that was. That was the last straw for me. I’ll never trust Barder again, and I’ve no idea what Hildreth has brought to the table. Only taken a lot off it, including that £40k bonus (whatever for?). The Market has been suggesting no “strong discussions†for some months now, and it does make one wonder if the placebo issue was unearthed in the due diligence carried out by 3rd parties last year. Good luck to all those who trust this lot. Looks like another very long road ahead and I cannot see a fund raise (which appears inevitable) getting much, if any, support. Surprised this bounced up from single digits, maybe very oversold in the morning. But my own valuation is based purely on hope driven by IMO a very untrustworthy incompetent management - £5 million tops (2.5p per share) and that’s only because it might be worth trading on the ramps.
Helloclouds
10 Dec 2019
Thoughts on Future Market Cap I’ve been in FUM for over 5 years now, it’s the only stock I hold that I still regard as a punt. I topped up today at 10 and 13 and now have just under 290K shares. I’m underwater until / if we get back to low 20s. I’m not sure we have to research " how it works " if we can prove that it does work , with lower side effect profile. In the webcast they discussed option of licencing as a medical device which they believe they already have cleared all of the hurdles required in the US. They’ve got a couple of good KOL quotes on the results from HCPs in the ED field so I think they still have a viable product. Agreed, that the possibility of further dilution is a worry but I’d already written off this chunk of my portfolio as a possible total loss but everything else I hold is pretty dull with nothing like the potential upside…
Aberdeen_investor
10 Dec 2019
Thoughts on Future Market Cap well what I don’t understand is this… Trials were conducted on MED at low concentrations of GTN… It was widely stated that no increase in blood flow was observed (using dermasys) at very low concentrations of GTN………………however we are then told as the GTN levels were increased blood flow increased significantly at the 0.2%. Therefore leading to the hypothesis that it was indeed GTN that was increasing blood flow since the constant in all of this was the dermasys and only variable was the GTN concentration. How can it therefore be Dermasys alone now, that achieves the increased blood flow. Were those earlier trials flawed then in some way? We don’t know the full story and it’s absolute bonkers.
fx2452
10 Dec 2019
Thoughts on Future Market Cap 31.5 million shares traded today (a touch up on the average volume of the past few weeks!). Damn shame this volume wasn’t after good news.
trump53
10 Dec 2019
Thoughts on Future Market Cap FUM now find themselves in possession of compelling results from a phase 3 study, - for the placebo. Regulators will tell Ken they like the work done, but they will need to know exactly how the placebo achieves these outcomes. The webcast is weak on this subject (unsurprisingly), so I won’t be surprised if Futura do not approach the regulators until they have a story to tell them: How Placebo satisfies the outcomes. How the train of events with the PK, Phase2 and Phase3 studies combined to hide the real ‘active’ until after phase 3 closed, (bar the ongoing 6 month / 1 yr safety study). I would like to see the company state what differences in placebo there were for the 3 studies mentioned, and the reasons for any changes. I would like to see exactly what has been patented yesterday. I don’t think many posters here can kick themselves too hard about their actions, after was has been revealed today, In the RNS, which caused maximum confusion, - and people quickly start selling when that happens. In the presentation with all its surprises.
tomasccc52
10 Dec 2019
Thoughts on Future Market Cap I agree with all that. Every time I had doubts I would tell myself that Ken James and Barder and everyone else in their circle have experimented with this stuff for years and surely know it works or they wouldn’t have jumped through all these hoops for all these years. So many things make no sense. Oh well I was swinging for the fence for my grandkids education and struck out. Education costs some serious money over here.
Aberdeen_investor
10 Dec 2019
Thoughts on Future Market Cap All I know is I feel like I’ve been kicked in the balls several times. I have still not got over the dilution that we faced last time and my balls have barely recovered only for them to be kicked again. I’m not sure what to make of all this. They can be kicked again and I wouldn’t feel a thing as they are so swollen I can’t even sit down right now. I just cannot understand how MED could have been used for this long and no one thought of carrying out a trial beforehand with just the dermasys as Placebo. It would have saved years and years of pain. I spent a whole bloody weekend phoning up pharmacies in Saudi Arabia asking for the Super Manex Condoms only to be told they were out of stock but yet, we had shipped stock so God knows where that stock went. After being a share holder for so long and such a supporter I can truly feel the pain of other long term share holders and feel the pain of Tony too. I’ll watch from the sidelines now but I seriously wish every share holder good luck! I’ve taken a heavy loss today however life goes on. Might venture back in but there is too much uncertainty for me at the moment.
tomasccc52
10 Dec 2019
Thoughts on Future Market Cap The Cialis dose of 5 mg is the absolute lowest dose of any pde5 inhibitor. It is meant to be taken daily so that it builds up in your system. Why wasn’t all this efficacy among all patient groups shown in phase 2?
Helloclouds
10 Dec 2019
Thoughts on Future Market Cap The webcast shows that the action of the Demasys delivers nitric oxide into the glans - they believe this casues the reaction. The side effect profile is minimal and the effectiveness is just lower than cialis and twice as effective as the only other topical product licenced.
trump53
10 Dec 2019
Thoughts on Future Market Cap Currently trying to find descriptions of the placebo used in the PK study, phase 2 and phase 3 studies. So far have not found Placebo description to be good enough to know whether different substances were used in these trials. Experiencing internet connection problems, and have not been able to watch today’s webcast, but will persevere.
markthemango1
10 Dec 2019
Thoughts on Future Market Cap The big thing is differentiating from the placebo. At the end of the day for all we know, the people who did the study might’ve got hard from putting any gel on their knob. I feel like this is a massive problem that can’t really be solved, our gel doesn’t work in severe patients but then the mild to moderate ones can get hard too easily. I feel this is the end for FUM really unless they can prove a difference between Dermasys gel and normal gel. Can only see funds needed to be raised soon at 6pish again. And don’t forget they’ll have taken their nice bonuses for the hard work they’ve done…
ZeroV
10 Dec 2019
Thoughts on Future Market Cap Very interesting development though so not all bad, at all. The concern is how to get to market (ie more testing, but potentially not?) and how much is that going to cost. To me, this should still be very very attractive to buyers, especially if we get the patent extension and especially if more testing is not required. Until the funding side of things are cleared, I fear we will be floundering for a bit. Ironically, if only they had used a different placebo, this would read completely differently.
ZeroV
10 Dec 2019
Thoughts on Future Market Cap Sadly also out.
Emtee
10 Dec 2019
Thoughts on Future Market Cap I sincerely hope Barder is hosting Xmas dinner at his place and the in laws are invited,
